Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 1 , Pages 38-41 , March 2008

Current practice in management of high-grade dysplasia in Barrett's oesophagus: The real problem

References 

  1. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C. Barrett's metaplasia. Lancet. 2000;356:2079–2085
  2. Barr H, Maynard N. Controversies in surgery: high-grade dysplasia in Barrett's oesophagus. Ann R Coll Surg Engl. 2007;89:586–590
  3. Lagergren J, Bergstrom R, Lindren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825–831
  4. Marx J. Anti-inflammatories inhibit cancer growth-but how?. Science. 2001;291:581–582
  5. Bailey T, Biddlestone L, Shepherd N, Barr H, Warner P, Jankowski J. Altered cadherin and catenin complexes in the Barrett's esophagus–dysplasia–adenocarcinoma sequence. Am J Pathol. 1998;152:1–10
  6. Ouata-Lascar R, Fitzgerald RC, Triadafilopoulos G. Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression. Gastroenterology. 1999;117:327–335
  7. Peters FTM, Ganesh S, Kuipers EJ, et al. Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study. Gut. 1999;45:489–494
  8. Sagar PM, Ackroyd R, Hosie KB, Patterson JE, Stoddard CJ, Kingsnorth AN. Regression and progression of Barrett's oesophagus after antireflux surgery. Br J Surg. 1995;82:806–810
  9. Barr H, Shepherd NA, Dix A, Roberts DJH, Tan WC, Krasner N. Eradication of high grade dysplasia in columnar-lined (Barrett's) oesophagus using photodynamic therapy with endogenously generated protoporphyrin IX. Lancet. 1996;348:584–585
  10. Biddlestone LR, Barham CP, Wilkinson SP, Barr H, Shepherd NA. The histopathology of treated Barrett's esophagus. Am J Surg Pathol. 1998;22:239–245
  11. Barr H, Dix AJ, Stone N. Optical spectroscopy for the early diagnosis of gastrointestinal malignancy lasers. Med Sci. 1998;13:3–13
  12. Ortiz A, Martinez de Haro LF, Parrilla P, et al. Conservative treatment versus antireflux surgery in Barrett's oesophagus: long-term results of a prospective study. Br J Surg. 1996;83:274–278
  13. Montgomery E, Bronner MP, Goldblum JR, et al. Reproducibility of the diagnosis of dysplasia in Barrett's oesophagus: a reaffirmation. Hum Pathol. 2001;32:368–378
  14. Ormsby AH, Petras RE, Henricks WH, et al. Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut. 2002;51:671–676
  15. Schnell TG, Sontag SJ, Chejfec G, et al. Long term non-surgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 2001;120:1607–1619
  16. Kara MA, Bergman JGHM, Tytgat GNJ. Follow-up for high-grade dysplasia in Barrett's oesophagus. Gastrointest Endosc Clin N Am. 2003;13:513–533
  17. Montgomery E, Goldblum JR, Greenson JK, et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from diagnostic variability study. Hum Pathol. 2001;32:379–388
  18. Zaninotto P, Parenti AR, Ruol A, Costantini M, Merigliano S, Ancona E. Oesophageal resection for high-grade dysplasia in Barrett's oesophagus. BJS. 2000;97:1102–1105
  19. Overholt BF, Lightdale CJ, Wang KK, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded randomized phase III trial. Gastrointest Endosc. 2005;62:488–498
  20. Barr H, Stone N, Rembacken B. Endoscopic therapy for Barrett's oesophagus. Gut. 2005;54:875–884
  21. Shetty G, Kendall C, Shepherd N, Stone N, Barr H. Raman spectroscopy: elucidation of biochemical changes in carcinogenesis of oesophagus. Br J Cancer. 2006;94:1460–1464

PII: S1572-1000(08)00005-7

doi: 10.1016/j.pdpdt.2008.01.004

Photodiagnosis and Photodynamic Therapy
Volume 5, Issue 1 , Pages 38-41 , March 2008

Article Tools